{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:27:19Z","timestamp":1762176439507},"reference-count":13,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T00:00:00Z","timestamp":1206057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Aim\u2002<\/jats:bold> To examine use of acid\u2010decreasing medications, especially proton pump inhibitors (PPIs), in patients with gastro\u2010oesophageal reflux disorder (GERD) with and without Barrett\u2019s oesophagus (BO) in a large\u2010scale study.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> We conducted a retrospective cohort study of patients with newly diagnosed BO (<jats:italic>ICD\u20109<\/jats:italic> code 5302) and patients with GERD and no BO (<jats:italic>ICD\u20109<\/jats:italic> 53081, 5301) in Department of Veterans Affairs (VA) databases. Filled prescriptions for oral PPI and histamine2\u2010receptor antagonists (H2RA) were identified in the VA Pharmacy Benefit Management database during 365\u2003days following diagnosis. Groups with or without PPI or H2RA were compared in unadjusted and adjusted regression analyses. Chart review was used to validate diagnoses in a subset of patients with and without BO.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> We evaluated 7732 patients with BO and 13\u2003457 with GERD and no BO diagnosed between 1\/2000 and 12\/2002. At least one PPI prescription was filled during the first year following diagnosis in 91.5% of BO and 61.4% of non\u2010BO patients (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001), and one H2RA in 31.7% of BO and 59.4% of non\u2010BO patients (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001), respectively. However, 6.1% of BO patients were prescribed neither. Median duration for PPI filled prescriptions was twice as long for BO (221.7 vs. 106.9\u2003days) compared with non\u2010BO patients. The ratio of PPI or H2RA filled prescription days to available follow\u2010up days among BO subjects was 0.66 (122.8\u2003days were not covered with prescription for either), and 0.55 in GERD patients with no BO (165.0\u2003days on neither).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Veterans Affairs patients with BO are 50% more likely to be prescribed a PPI than patients with GERD and no BO. However, on average, PPI prescriptions cover only 60% of follow\u2010up time for BO patients.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2008.03690.x","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T17:23:59Z","timestamp":1279819439000},"page":"1293-1299","source":"Crossref","is-referenced-by-count":9,"title":["The use of acid\u2010decreasing medication in veteran patients with gastro\u2010oesophageal reflux disorder with and without Barrett\u2019s oesophagus"],"prefix":"10.1111","volume":"27","author":[{"given":"H. B.","family":"EL\u2010SERAG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"WIEMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"RICHARDSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,21]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"27","article-title":"The relationship between gastroesophageal reflux disease and its complications with Barrett\u2019s esophagus","volume":"92","author":"Eisen GM","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_3_2","first-page":"1293","article-title":"Risk factors for Barrett\u2019s esophagus in community\u2010based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy","volume":"92","author":"Lieberman DA","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05910.x"},{"issue":"5","key":"e_1_2_6_6_2","first-page":"79S","article-title":"Barrett esophagus: will effective treatment prevent the risk of progression to esophageal adenocarcinoma?","volume":"117","author":"Sharma P","year":"2004","journal-title":"Am J Med"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200211000-00005"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00749.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30228.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2004.tb05991.x"},{"key":"e_1_2_6_11_2","first-page":"104","article-title":"Pharmacy benefits management in the Veterans Health Administration: 1995 to 2003","volume":"11","author":"Sales MM","year":"2005","journal-title":"Am J Manag Care"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117426"},{"key":"e_1_2_6_13_2","author":"Morgan R","year":"2004","journal-title":"Individual-level Factors Affecting Enrollment in Medicare\u2003+\u2003Choice Plans and Use of VA Medical Care by Medicare Enrolled White, African American and Hispanic Veterans"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/1077558703060002007"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2008.03690.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2008.03690.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:34:58Z","timestamp":1697193298000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2008.03690.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,21]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1365-2036.2008.03690.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03690.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,21]]}}}